HOTAIRM1 and cancer: As a biomarker combination could be more powerful than a single biomarker, we decided to evaluate, in the same EV samples, the expression of other lncRNAs whose expression in tissue impacted prognosis in other cancers studied by our group [39,40], including HOTTIP, HOTAIR, HOXA11, and HOTAIRM1.